 2
中 文 摘 要 
女性停經症狀包括顏面熱潮紅、流冷
汗、盜汗、憂鬱、焦慮及煩躁等現象。而
自主神經調控在更年期婦女之停經症狀的
調控方面可能扮演著某些角色，本研究想
探討自主神經功能、女性賀爾蒙與停經症
狀之間的相關性。本研究對象為97位45-65
歲女性，皆無人使用影響心跳變異性之藥
物。停經症狀採 Greene scale 計分，包括
somatic、psychological 及 vasomotor 症狀。
爾 蒙 檢 查 包 括 estradiol 及 follicle 
stimulating hormone。自主神經功能以心跳
變異性作評估，以 Polar T34 Transmitter 作
心跳之傳輸；溫度以 TI TMP123 溫度 IC
作測量。單變項分析顯示自主神經功能中
的 PNN50、RMMSD、LF 及 HF power 與
somatic 及 psychological 症狀呈顯著的負相
關；但 vasomotor 症狀與自主神經功能則
無相關；溫度與停經症狀並無相關性。複
迴歸分析顯示 PNN50、RMMSD、LF power
及 E2 濃度與停經症狀總分數呈獨立的負
相關。somatic 症狀與 PNN50、RMMSD
及 HF power 呈 獨 立 的 負 相 關 ；
psychological 症狀與 PNN50、RMMSD 及
LF power 呈負相關；vasomotor 症狀並不與
任何自主神經功能指標有獨立的相關性。
自主神經功能 PNN50、RMMSD、LF 及
HF power 與血中 E2 濃度有獨立的正相
關。因此本研究之結論為更年期婦女停經
症狀與自主神經功能減少，尤其是副交感
神經功能及血中雌性激素濃度的減少有
關。血中雌性激素的減少與自主神經功能
的降低有關。 
 
關鍵詞：停經症狀、自主神經功能、雌素
二醇 
ABSTRACT 
Menopausal symptoms include hot flush, 
cold and night sweating, depression, anxiety, 
and irritability. The association between 
autonomic function and menopausal 
symptoms is to be clarified. The aim of this 
study is to investigate the relationship among 
menopausal symptoms, autonomic function, 
and plasma level of estradiol and follicle 
stimulating hormone. A total of 97 females 
with age of 45 -65 years were included. 
Autonomic function was defined by heart 
rate variability. Heart rate and body 
temperature were measured by Polar T34 
Transmitter and TI TMP123 IC. Univariate 
analysis showed autonomic function, shown 
by PNN50, RMMSD, LF and HF power, was 
inversely associated with somatic and 
psychological symptom score. Vasomotor 
symptom score was not related to any indices 
of autonomic function. Body temperature 
was not associated with any menopausal 
symptom score. Multivariate analysis 
revealed that total symptom score was 
negatively correlated to the following: 
PNN50, RMMSD, LF power, and plasma 
etradiol level. There was an independently 
inverse relationship between somatic 
symptom score and autonomic function 
(PNN50, RMMSD, and HF power). PNN50, 
RMMSD, and LF power were negatively 
associated with psychological symptom 
score.  A positive correlation was found 
between autonomic function and plasma 
etradiol level. In conclusion, menopausal 
symptoms were related to autonomic 
dysfunction, especially the parasympathetic 
function, and decreased plasma etradiol level. 
The lower the autonomic function, the lower 
the plasma etradiol level. 
Keywords：  menopausal symptoms, 
autonomic function, estradiol 
 4
獨立相關性，顯著差異 p 值定為小於 0.05。 
 
結   果 
本研究之研究對象共有 97 位女性，基
本資料如表 1 所述。圖一顯示心跳、RR 間
距及溫度訊號測量結果分析之 GUI 介面，
從圖一擷取某一段心跳、RR 間距及溫度訊
號的放大畫面如圖二所示。 
表 2 顯示臨床變項、自主神經功能、
與停經症狀之相關性。結果顯示年齡、身
體質量指數、血壓、心跳、體溫、血糖、
血脂肪、血中 E2 濃度、及 LF/HF 等臨床
變項與停經症狀並無相關性。自主神經功
能中的 PNN50、RMMSD、LF 及 HF power
與 somatic及psychological症狀呈顯著的負
相關；但 vasomotor 症狀與自主神經功能
則無顯著相關。另外血中 FSH 濃度與
psychological 症狀呈正相關。 
以複迴歸分析調整其它因素作自主神
經功能與停經症狀相關性之探討，調整因
素包括年齡、身體質量指數及血中 E2 濃
度，結果顯示 PNN50、RMMSD、LF power
及血中 E2 濃度與停經症狀總分數呈獨立
的負相關 (表 3)。如將停經症狀分為
somatic、psychological 及 vasomotor 症狀
三類，E2 濃度與上述三類停經症狀並無獨
立的相關性 ( 表 4) 。 somatic 症狀與
PNN50、RMMSD 及 HF power 呈獨立的負
相關；PNN50、RMMSD 及 LF power 與
psychological 症狀呈負相關；vasomotor 症
狀與任何自主神經功能指標則無獨立的相
關性(表 4)。 
表 5 顯示自主神經功能 PNN50、
RMMSD、LF 及 HF power 與血中 E2 濃度
有獨立的正相關，但 LF/HF 則與與血中 E2
濃度無關。 
 
討   論 
本研究結果顯示停經症狀與心跳變異
性減少有明顯的關聯，因此自主神經功能
對於停經症狀的發生仍有其相關，雖然文
獻顯示停經後自主神經系統對於心血管的
調控會有所改變[13-15]，但其機轉仍不
明。本研究也顯示 somatic 與 psychological
症狀與心跳變異性減少有關，尤其是高頻
率能量，這顯示副交感神經調控功能減少
可能與這些停經症狀發生的機制有關，此
與其他文獻顯示停經婦女心臟自主神經功
能減少相類似[16,17]。 
文獻顯示壓力、恐慌、焦慮及憂鬱與
心跳變異性的減少有關[18]。本研究也顯示 
停經症狀中的 somatic及psychological症狀
與心跳變異性減少有關。是否停經相關的
身體不適、焦慮及憂鬱症狀造成的心跳變
異性減少，與壓力、恐慌、焦慮及憂鬱造
成的心跳變異性減少有相同機轉，有待進
一步研究。 
雖然賀爾蒙補充治療可以改善有停經
症狀婦女之症狀，又本研究也顯示停經症
狀的嚴重度會隨著血中 E2 濃度的減少而
增加，但本研究如果將停經症狀分為
somatic、psychological 及 vasomotor 症狀
 6
biochemistry. Pergamon, New York, 
1990;pp255-307. 
11. Greene JG. Constructing a standard 
climacteric scale. Maturitas 
1998;29:25-31. 
12. Task Force on the European Society of 
Cardiology and the North American 
Society of Pacing and Electrophysiology. 
Heart rate variability – standards of 
measurement, physiological 
interpretation, and clinical use. 
Circulation 1996;1043-65. 
13. Mercuro G, Longu G, Zoncu S, Cherchi 
A. Impaired forearm blood flow and 
vasodilator reserve in healthy 
postmenopausal women. Am Heart J 
1999;137:692–7. 
14. Owens JF, Stoney CM, Matthews KA. 
Menopausal status influences ambulatory 
blood pressure levels and blood pressure 
changes during mental stress. Circulation 
1993;88:2794–802. 
15. Saab PG, Matthews KA, Stoney CM, 
McDonald RH. Premenopausal and 
postmenopausal women differ in their 
cardiovascular and neuroendocrine 
responses to behavioral stressors. 
Psychophysiology 1989;26:270–80. 
16. Brockbank CL, Chatterjee F, Bruce SA, 
Woledge RC. Heart rate and its 
variability change after the menopause. 
Exp Physiol 2000;85:327–330. 
17. Rosano GM, Patrizi R, Leonardo F, et al. 
Effect of estrogen replacement therapy 
on heart rate variability and heart rate in 
healthy postmenopausal women. Am J 
Cardiol 1997;80:815–7. 
18. Cohen H, Benjamin J. Power spectrum 
analysis and cardiovascular morbidity in 
anxiety disorders. Auton Neurosci 
2006;128:1-8. 
19. Hutton JD, Jacobs HS, Murray MA, 
James VH. Relation between plasma 
oestrone and oestradiol and climacteric 
symptoms. Lancet 1978;1:678-81. 
20. Aksel S, Schomberg DW, Tyrey L, 
Hammond CB. Vasomotor symptoms, 
serum estrogens, and gonadotropin levels 
in surgical menopause. Am J Obstet 
Gynecol 1976;126:165-9. 
21. Stone SC, Mickal A, Rye PH. 
Postmenopausal symptomatology, 
maturation index, and plasma estrogen 
levels. Obstet Gynecol 1975;45:625-7. 
22. Farag NH, Nelesen RA, Parry BL, et al. 
Autonomic and cardiovascular function 
in postmenopausal women: the effects of 
estrogen versus combination therapy. Am 
J Obstet Gynecol 2002;186:954-61. 
 
 8
Table 1. Clinical characteristics in study subjects 
Variables Mean ± SD or Percentage 
Age, year 56.7±7.2 
Body height, cm 153.9±5.1 
Body weight, kg 54.7±6.2 
Body mass index, kg/m2 23.1±2.5 
Systolic blood pressure, mmHg 120.9±12.6 
Diastolic blood pressure, mmHg 75.3±3.9 
Heart rate, beat/min 71.8±8.7 
Body temperature, °C 35.56±0.19 
Fasting plasma glucose, mg/dl 88.4±15.1 
Cholesterol, mg/dl 209.9±33.8 
Triglyceride, mg/dl 125.3±78.7 
HDL-C, mg/dl 53.9±11.6 
Estradiol (E2), pg/ml 52.1±38.7 
Follicle stimulating hormone (FSH), U/L 33.4±25.0 
Menopausal symptoms  
Vasomotor symptom, % 27.6 
Somatic symptom, % 81.6 
Psychological symptom, % 82.7 
 
